164 related articles for article (PubMed ID: 2666676)
1. Combination iron depletion therapy.
Taetle R; Honeysett JM; Bergeron R
J Natl Cancer Inst; 1989 Aug; 81(16):1229-35. PubMed ID: 2666676
[TBL] [Abstract][Full Text] [Related]
2. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.
White S; Taetle R; Seligman PA; Rutherford M; Trowbridge IS
Cancer Res; 1990 Oct; 50(19):6295-301. PubMed ID: 2400993
[TBL] [Abstract][Full Text] [Related]
3. Modulation of transferrin receptor mRNA by transferrin-gallium in human myeloid HL60 and lymphoid CCRF-CEM leukaemic cells.
Ul-Haq R; Chitambar CR
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):873-7. PubMed ID: 8379943
[TBL] [Abstract][Full Text] [Related]
4. Development of drug resistance to gallium nitrate through modulation of cellular iron uptake.
Chitambar CR; Zivkovic-Gilgenbach Z; Narasimhan J; Antholine WE
Cancer Res; 1990 Aug; 50(15):4468-72. PubMed ID: 2164439
[TBL] [Abstract][Full Text] [Related]
5. Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody.
Taetle R; Rhyner K; Castagnola J; To D; Mendelsohn J
J Clin Invest; 1985 Mar; 75(3):1061-7. PubMed ID: 2984253
[TBL] [Abstract][Full Text] [Related]
6. Characterization of L1210 cell growth inhibition by the bacterial iron chelators parabactin and compound II.
Cavanaugh PF; Porter CW; Tukalo D; Frankfurt OS; Pavelic ZP; Bergeron RJ
Cancer Res; 1985 Oct; 45(10):4754-9. PubMed ID: 4027962
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of leukemic HL60 cell growth by transferrin-gallium: effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea.
Chitambar CR; Matthaeus WG; Antholine WE; Graff K; O'Brien WJ
Blood; 1988 Dec; 72(6):1930-6. PubMed ID: 3058232
[TBL] [Abstract][Full Text] [Related]
8. Transferrin receptor-mediated suppression of in vitro hematopoiesis by transferrin-gallium.
Chitambar CR; Craig A; Ash RC
Exp Hematol; 1989 Jun; 17(5):418-22. PubMed ID: 2714421
[TBL] [Abstract][Full Text] [Related]
9. Regulatory effects of gallium on transferrin-independent iron uptake by human leukemic HL60 cells.
Chitambar CR; Sax D
Blood; 1992 Jul; 80(2):505-11. PubMed ID: 1627803
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of transferrin and gallium-pyridoxal isonicotinoyl hydrazone as potential therapeutic agents to overcome lymphoid leukemic cell resistance to gallium nitrate.
Chitambar CR; Boon P; Wereley JP
Clin Cancer Res; 1996 Jun; 2(6):1009-15. PubMed ID: 9816262
[TBL] [Abstract][Full Text] [Related]
11. Interaction of gallium nitrate with fludarabine and iron chelators: effects on the proliferation of human leukemic HL60 cells.
Lundberg JH; Chitambar CR
Cancer Res; 1990 Oct; 50(20):6466-70. PubMed ID: 1698536
[TBL] [Abstract][Full Text] [Related]
12. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia.
Sauvage CA; Mendelsohn JC; Lesley JF; Trowbridge IS
Cancer Res; 1987 Feb; 47(3):747-53. PubMed ID: 3802079
[TBL] [Abstract][Full Text] [Related]
13. Effects of monoclonal anti-transferrin receptor antibodies on in vitro growth of human solid tumor cells.
Taetle R; Honeysett JM
Cancer Res; 1987 Apr; 47(8):2040-4. PubMed ID: 3828993
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
[TBL] [Abstract][Full Text] [Related]
15. Targeting iron-dependent DNA synthesis with gallium and transferrin-gallium.
Chitambar CR; Narasimhan J
Pathobiology; 1991; 59(1):3-10. PubMed ID: 1645976
[TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibition of lymphoid tumor growth in vitro by combined treatment with the iron chelator deferoxamine and an immunoglobulin G monoclonal antibody against the transferrin receptor.
Kemp JD; Smith KM; Kanner LJ; Gomez F; Thorson JA; Naumann PW
Blood; 1990 Sep; 76(5):991-5. PubMed ID: 2393721
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-transferrin receptor antibodies on growth of normal and malignant myeloid cells.
Taetle R; Honeysett JM; Trowbridge I
Int J Cancer; 1983 Sep; 32(3):343-9. PubMed ID: 6309680
[TBL] [Abstract][Full Text] [Related]
18. Microbial iron chelator-induced cell cycle synchronization in L1210 cells: potential in combination chemotherapy.
Bergeron RJ; Ingeno MJ
Cancer Res; 1987 Nov; 47(22):6010-6. PubMed ID: 3664504
[TBL] [Abstract][Full Text] [Related]
19. A recombinant fusion toxin targeted to the granulocyte-macrophage colony-stimulating factor receptor.
Bendel AE; Shao Y; Davies SM; Warman B; Yang CH; Waddick KG; Uckun FM; Perentesis JP
Leuk Lymphoma; 1997 Apr; 25(3-4):257-70. PubMed ID: 9168436
[TBL] [Abstract][Full Text] [Related]
20. Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro.
Bieber MM; Twist CJ; Bhat NM; Teng NN
Pediatr Blood Cancer; 2007 Apr; 48(4):380-6. PubMed ID: 16421902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
